Phase I / II study of XELOX plus bevacizumab in Japanese patients with metastatic colorectal cancer (JO19380): Evaluation of long-term treatment cases
- Atsushi Sato
- , Toshihiko Doi
- , Narikazu Boku
- , Ken Kato
- , Yoshito Komatsu
- , Kensei Yamaguchi
- , Kei Muro
- , Yasuo Hamamoto
- , Wasaburo Koizumi
- , Nobuyuki Mizunuma
- , Hiroya Takiuchi
Research output: Contribution to journal › Review article › peer-review
4
Link opens in a new tab
Citations
(Scopus)